MOMTAZEE JAMES C 4

What Happened
James C. Momtazee, a director of Roivant Sciences (ROIV), was awarded 609 common shares on 2026-01-20 under the company's Non-Employee Director Compensation Plan; the award was fully vested as of the grant date. To satisfy tax withholding on the vested shares, 122 shares were net-settled (disposed) to the issuer at an implied price of $22.98 per share, resulting in $2,804 withheld.

Key Details

• Transaction dates: 2026-01-20 (award and net settlement for taxes). Form filed 2026-01-22.
• Award: 609 shares granted, $0.00 acquisition price (vesting-based award).
• Tax withholding: 122 shares disposed at $22.98 each, totaling $2,804 (net settlement by issuer).
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: F1 = award was fully vested at grant. F2 = the 122-share disposal reflects the issuer's net settlement to satisfy tax withholding.
• Timeliness: Filing covers a 2026-01-20 transaction and was submitted 2026-01-22 (appears timely).

Context: This was a vested director award (not an option exercise or open-market trade). The 122-share disposal was a routine, issuer-handled net settlement to cover withholding taxes and is standard for equity compensation — it should not be interpreted as an independent sell signal about company prospects.